Elizabeth Kennedy

Elizabeth (Liz) Kennedy is a senior product leader with deep experience building and scaling customer-centric products that integrate hardware, software, and services to deliver measurable business impact. She has spent over a decade leading innovative, computer-vision-and AI-powered products, including Amazon’s Echo Look and clothing Virtual Try-On, translating cutting-edge technology into intuitive customer experiences at scale. Her work at Amazon spanned defining end-to-end product requirements and customer journeys across ecommerce, automotive, and healthcare. Liz began her career in automotive new vehicle development at GM and Nissan and is now focused on bringing this blend of deep technical products, complex systems thinking, and customer obsession to mission-driven organizations in the Detroit region

The post Elizabeth Kennedy TALKS ABOUT AI, EARLY DETECTION OF DISEASE AND COMPUTER VISION appeared first on Good News!.

www.vascularcures.org

When most people think of heart disease, their association is with coronary artery disease (CAD), where fatty deposits and plaque can build up in the arteries that carry blood from your heart through the body. But artery disease can affect more than just the heart. The limited blood flow caused by artery disease can be dangerous, leading to blood clots and a lesser known but very serious disease called peripheral artery disease (PAD).

CAD is the most common type of heart disease and is the greatest cause of morbidity and mortality in the U.S.1 Approximately 18.2 million adults over age 20 are living with CAD in the U.S.2 PAD affects an estimated 20 million Americans,3 yet only approximately 8.5 million are diagnosed.4 If left untreated, CAD and PAD can increase the risk of serious health outcomes such as heart attack, stroke,5 and – in the case of PAD – acute limb ischemia or even a lower limb amputation.6

It’s important to be aware of the potential connection between these two artery diseases. If you have CAD, you may have an increased risk of PAD – and vice versa.6 In fact, more than 40% of individuals with CAD also have PAD.1

Further, these conditions have overlapping risk factors – including hypertension (high blood pressure), diabetes and smoking (even formerly smoking).6 In fact, smoking is the most common preventable cause of PAD.7 Up to 90 percent of people with PAD have a history of smoking,8 and smokers have a 4x greater risk of PAD than nonsmokers.9

Early detection is key to reducing the chance of serious outcomes. Knowing your risk of CAD and PAD – and talking to your doctor – are important first steps.

Dr. Veita Bland, renowned hypertension specialist and family physician, and Pamela Parker, PAD patient and passionate advocate for artery disease awareness, discusses the importance of early detection, intervention and management of CAD and PAD.

Interview courtesy: Janssen Pharmaceuticals, Inc

IT’S HEARTHEALTH MONTH AND AN IMPORTANT TIME TO TALK ABOUT ARTERY DISEASE.

[ALT, if live or airing before February 1: HEART HEALTH MONTH IS JUST AROUND THE CORNER AND IT’S ANIMPORTANT TIME TO TALK ABOUT ARTERY DISEASE.]

ARTERY DISEASECAN AFFECT MORE THAN JUST YOUR HEART AND EARLY DETECTION IS KEY TO REDUCING THECHANCE OF SERIOUS OUTCOMES.

HERE TO TALKABOUT WHAT YOU NEED TO KNOW ABOUT CORONARY ARTERY DISEASE (C-A-D) AND A RELATEDCONDITION, CALLED PERIPHERAL ARTERY DISEASE (P-A-D), ARE FAMILY PHYSICIAN ANDRENOWNED HYPERTENSION SPECIALIST, DR. VEITA (“Veeta”) BLAND, ALONG WITH P-A-DPATIENT AND ADVOCATE, PAMELA.

BIO’S:

Dr. Veita Bland, Family Physician and Renowned Hypertension Specialist

Dr. Veita Bland is a practicing physician in Greensboro, North Carolina. She is a graduate of Bennett College, Temple University School of Medicine, and the residency program at The University of Maryland. She is board certified in Family Medicine and is a Certified Clinical Hypertension Specialist.

She has spent her career making sure her patients are informed about their health so they understand why taking care of their health is important and can pass down the correct information about their disease to others.

To that end, she is a columnist of medical articles for papers across the country and is the host of the nationally syndicated podcast, “It’s A Matter of Your Health: The30 Min Health Magazine”.

She believes that we all teach each other. So let’s get the information right.

Pam, PAD Patient and Advocate

Pam is a Health and Physical Education Educator in Washington D.C.’s public school system, a heart attack survivor, and a Champion of Women Heart, a non-profit organization that seeks to improve the health and quality of life of women living with or at risk of heart disease.

Pam has educated and empowered others for more than 25 years. She has consistently earned the ranking of Highly Effective Teacher and this year she was honored to be a Physical Education Emerging Leaders (PEEL) Fellowship Candidate. The fellowship builds teacher capacity and establishes schools that serve as a district-wide model of implementing a successful Health and Physical Education program amongst D.C. public schools.

Pam was diagnosed with PAD in 2009, which included immediate surgery to clear blockages in her legs, and suffered a heart attack in 2014. Her experiences led her to advocate in the heart health space. She is passionate about equipping youth –and all of us – with the knowledge and tools to make smart, healthy decisions. Presently, Pam is in the process of writing a children’s book, titled, “I Love My Heart”.

Pam has shared her experiences with Good Morning Washington in 2018 as well as the U.S. House of Representative in 2019. She has spoken at briefings on Capitol Hill, a panel with Vascular Cures and other events engaging lawmakers to inform future health policy.

#veita #bland #pam #vascular #cures #vascularcures #artery #disease #heart #coronary #peripheral #cad #pad #fatty #plaque #blood #diagnosed #janssen #pharmaceuticals #detection

The post Artery Disease Can Affect More Than Just Your Heart appeared first on Good News!.

Listen to “September: Prostate Cancer Awareness Month NEW METHODS IN PROSTATE CANCER DETECTION.We speak to Dr. Earle Burgess, an oncologist from Charlo” on Spreaker.

National Prostate Health Month (NPHM), also known as National Prostate Cancer Awareness Month, is observed every September in the United States (US) by health experts, health advocates, and individuals concerned with men’s prostate health and prostate cancer.

We speak to Dr. Earle Burgess, an oncologist from Charlotte, North Carolina.

Other than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society’s estimates for prostate cancer in the US for 2021 are1:
• About 248,530 new cases of prostate cancer
• About 34,130 deaths from prostate cancer
Once someone is diagnosed with prostate cancer, the patient and their doctor continue to check the prostate- specific antigen, or PSA, which can be measured through a routine blood test. A rise in PSA can indicate whether the cancer is progressing, but it cannot show where the cancer has spread.2
If the cancer is found to have spread to other parts of the body, also known as metastatic prostate cancer, it might be important to learn about a biomarker called prostate-specific membrane antigen, or PSMA, that can tell patients and their physicians so much more. A biomarker is a characteristic of a patient’s cancer that can be measured and provides a doctor more information about the cancer.
PSMA is found in more than 80% of men with prostate cancer.3 Although PSA and PSMA are both important biomarkers, they indicate different things.4
PSMA is identified with a positron emission tomography scan (an imaging scan) and can show a patient where the cancer has spread.5 PSMA can help give the doctor additional information to assess the progression of the prostate cancer and help inform the decision that both the patient and doctor will make regarding a treatment plan.
Now there is a new campaign launching to help people learn more and better understand what PSMA is and what it can tell a patient and doctor about the patient’s metastatic prostate cancer.
On Monday September 13, we will have an expert available to explain the importance of PSMA, an important yet underrecognized biomarker in the diagnosis of prostate cancer. The expert will also outline the details of the new PSMA campaign.
On Monday, September 1 3 , we willill hav explain the importance of PSMA, an important yet underrecognized biomarker in the diagnosis of prostate cancer. will also outline the details of the new PSMA campaign.
When you book a window, we’ll provide you with the guest’s biography & suggested questions.
Interview courtesy of Advanced Accelerator Applications, A Novartis Company.

The post September: Prostate Cancer Awareness Month NEW METHODS IN PROSTATE CANCER DETECTION.We speak to Dr. Earle Burgess, an oncologist from Charlotte, North Carolina appeared first on Good News!.

The post Prostate Cancer Awareness: Early detection saves lives ! appeared first on Good News!.